339.4500 -17.35 (-4.86%)
NSE Feb 06, 2026 15:31 PM
Volume: 940.4K
 

339.45
-4.86%
Business Line
The progress India has made in terms of building the capabilities and number of scientists work in its favour.Also, India has a much better regulatory record than how it was perceived about 7 and 8 years ago': Suven Pharma's Executive Chairman Vivek Sharma
Number of MF schemes decreased from 30 to 24 in Dec 2025 qtr
More from Cohance Lifesciences Ltd.
Recommended